Cancer BiologybioRxivPreprint
Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids
Emily E. Seiden, Spencer M. Richardson, Leah A. Everitt…·Edward M. Greenfield
This paper identifies romidepsin as a promising repurposed drug for osteosarcoma using 3D spheroid models, showing efficacy against metastatic cells and outperforming other HDIs.
1 citation